GAITHERSBURG, Md., May 06, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company, today announced that it will report its first quarter 2025 financial results on Tuesday, May 13, 2025.
Altimmune to Report First Quarter 2025 Financial Results and Provide Business Update on May 13, 2025
Seeking Alpha / 21 minutes from now 1 Views
Comments